S.B.
78
PHARMACY ACT AMENDMENTS
Senate Floor
Amendments
Amendment 3 March 6, 2013 1:26 PM
Senator Evan J. Vickers
proposes the following amendments:
1. Page
2, Line 45
:
45
58-17b-605, as last amended by Laws of Utah 2008, Chapter 205
63I-2-258, as last amended by Laws of Utah 2012, Chapters 88 and 369
2. Page
17, Lines 510 through 516
Senate Committee Amendments
2-21-2013
:
510
(8)
(a)
A pharmacist or pharmacy intern who substitutes an interchangeable biosimilar
511
product for a prescribed biological product shall:
512
{
(a)
}
(i)
notify the prescriber in writing S. , by fax, telephone, or electronic transmission .S
512a
of the substitution, as soon as practicable, but not
513
later than three business days after dispensing the interchangeable biosimilar product in place
514
of the prescribed biological product; and
515
{
(b)
}
(ii)
include the name and manufacturer of the interchangeable biosimilar product
516
substituted.
(b) This subsection is repealed on March 31, 2016.
3. Page
17, Line 521
Senate Committee Amendments
2-21-2013
:
521
authorized does not constitute evidence of negligence.
Section 4. Section 63I-2-258 is amended to read:
63I-2-258
.
Repeal dates -- Title 58.
(1) Subsection
58-72-201
(1)(b) is repealed July 1, 2014.
(2) Subsection 58-17b-606.5(8) is repealed on March 31, 2016.
Renumber remaining sections accordingly.
Page 1 of 1
LRGC
ajacobson
ajacobson